ArticleFrontiers in cellular and infection microbiology2026
Spatio-temporal differences and associations between upper and lower respiratory microbiota in ventilator-associated pneumonia.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: Ventilator-associated pneumonia (VAP) is a leading cause of morbidity and mortality in critically ill patients receiving mechanical ventilation for over 48 hours. This study aims to explore the spatiotemporal dynamics of respiratory microbiota in the upper (URT) and lower respiratory tracts (LRT) across three phases, including intubated controls, a newly defined VAP pre-occurrence phase, and confirmed VAP to identify early diagnostic biomarkers and enhance understanding of VAP pathophysiology. Methods: We analyzed 16S rRNA gene sequencing data from 123 samples retrieved from public database. Raw data were processed using the DADA2 pipeline for quality control and denoising. Taxonomy was assigned using the Silva 138 rRNA database. Alpha and beta diversity metrics were calculated, and LEfSe analysis was employed to identify differentially abundant taxa. The diagnostic potential of key bacterial genera was evaluated using ROC curve analysis, with precision, sensitivity, and specificity values reported. Results: URT alpha diversity increased significantly in VAP groups compared to controls and pre-VAP phase groups, with no significant changes in LRT alpha diversity. Beta diversity analysis revealed distinct microbial community structures across all three disease stages in both URT and LRT. Key genera, including Prevotella, Leptotrichia, and Peptostreptococcus, were identified as potential early diagnostic biomarkers, with high precision, sensitivity, and specificity. Microbial translocation from the URT to the LRT became increasingly synchronized by day 7 post-intubation, suggesting a critical window for intervention. Conclusions: This study highlights the dynamic changes in respiratory microbiota during VAP progression and identifies potential microbial biomarkers for early detection. These findings pave the way for microbiota-based diagnostic strategies and targeted interventions. Future research should validate these biomarkers in independent cohorts and explore their functional roles in VAP pathogenesis. Monitoring URT-LRT microbial interactions could enable proactive management of this devastating infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.